QuidelOrtho to Present at the J.P. Morgan Healthcare Conference
December 28 2022 - 7:00AM
Business Wire
QuidelOrtho Corporation (Nasdaq: QDEL) (“QuidelOrtho”), a
global provider of innovative in vitro diagnostics technologies
designed for point-of-care settings, clinical labs and transfusion
medicine, announced today that members of its management team are
scheduled to participate in the 41st Annual J.P. Morgan Healthcare
Conference in San Francisco beginning on January 9, 2023, with a
presentation scheduled for 9:00 a.m. PST / 12:00 p.m. EST.
Interested parties can access the live webcast and replay on the
“Events & Presentations” section of the “Investor Relations”
page of QuidelOrtho’s website at https://ir.quidelortho.com/.
About QuidelOrtho Corporation
QuidelOrtho Corporation (Nasdaq: QDEL) unites the power of
Quidel Corporation and Ortho Clinical Diagnostics behind a shared
mission of developing and manufacturing innovative technologies
that raise the performance of diagnostic testing and create better
patient outcomes across the entire healthcare continuum.
Ranked among the world’s largest in vitro diagnostics (IVD)
providers with more than 120 years of collective experience, we
combine industry-leading expertise in immunoassay and molecular
testing with a global footprint in clinical labs and transfusion
medicine.
Our company’s comprehensive product portfolio delivers accuracy,
speed, automation and access, providing critical information when
and where it is needed most. Inspired by a spirit of service,
QuidelOrtho is committed to enhancing the well-being of people
worldwide and happy in the knowledge we are making a difference.
For more information, please visit www.quidelortho.com.
Source: QuidelOrtho Corporation
View source
version on businesswire.com: https://www.businesswire.com/news/home/20221228005074/en/
Investor Contact: Bryan Brokmeier, CFA IR@Quidel.com
Media: media@Quidel.com
QuidelOrtho (NASDAQ:QDEL)
Historical Stock Chart
From May 2024 to Jun 2024
QuidelOrtho (NASDAQ:QDEL)
Historical Stock Chart
From Jun 2023 to Jun 2024